JPWO2019209078A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019209078A5 JPWO2019209078A5 JP2020559369A JP2020559369A JPWO2019209078A5 JP WO2019209078 A5 JPWO2019209078 A5 JP WO2019209078A5 JP 2020559369 A JP2020559369 A JP 2020559369A JP 2020559369 A JP2020559369 A JP 2020559369A JP WO2019209078 A5 JPWO2019209078 A5 JP WO2019209078A5
- Authority
- JP
- Japan
- Prior art keywords
- region
- fusion protein
- cancer
- immunoglobulin
- lrig
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2018-0048343 | 2018-04-26 | ||
| KR20180048343 | 2018-04-26 | ||
| PCT/KR2019/005096 WO2019209078A1 (ko) | 2018-04-26 | 2019-04-26 | 신규한 융합 단백질 및 이를 포함하는 암의 예방 또는 치료용 약학적 조성물 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021521817A JP2021521817A (ja) | 2021-08-30 |
| JPWO2019209078A5 true JPWO2019209078A5 (enExample) | 2022-04-19 |
| JP7485368B2 JP7485368B2 (ja) | 2024-05-16 |
Family
ID=68293649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020559369A Active JP7485368B2 (ja) | 2018-04-26 | 2019-04-26 | 新規な融合タンパク質およびこれを含む癌の予防または治療用薬学的組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US11820801B2 (enExample) |
| EP (1) | EP3792276A4 (enExample) |
| JP (1) | JP7485368B2 (enExample) |
| KR (3) | KR102194644B1 (enExample) |
| CN (1) | CN112041333B (enExample) |
| WO (1) | WO2019209078A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019309472A1 (en) * | 2018-07-24 | 2021-03-18 | Good T Cells, Inc. | Composition for preventing or treating immune-related diseases |
| JP7618240B2 (ja) * | 2019-03-20 | 2025-01-21 | グッド ティー セルズ、 インコーポレイテッド | 脳神経系疾患の予防または治療用組成物 |
| BR112022008730A2 (pt) * | 2019-11-08 | 2022-07-19 | Good T Cells Inc | Epítopo de antígeno de superfície de células t reguladoras e um anticorpo que se liga especificamente ao mesmo |
| CN111285936A (zh) * | 2020-03-11 | 2020-06-16 | 北京双赢科创生物科技有限公司 | 靶向肿瘤的酸性敏感纳米肽段及其应用 |
| KR20250036703A (ko) * | 2023-09-06 | 2025-03-14 | 주식회사 굳티셀 | 친화도 성숙이 이루어진 신규 항체 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU600575B2 (en) | 1987-03-18 | 1990-08-16 | Sb2, Inc. | Altered antibodies |
| US5116964A (en) | 1989-02-23 | 1992-05-26 | Genentech, Inc. | Hybrid immunoglobulins |
| US6086875A (en) | 1995-01-17 | 2000-07-11 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of immunogens |
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| AU728657B2 (en) | 1996-03-18 | 2001-01-18 | Board Of Regents, The University Of Texas System | Immunoglobulin-like domains with increased half-lives |
| WO2005063808A1 (en) * | 2003-12-31 | 2005-07-14 | Merck Patent Gmbh | Fc-ERYTHROPOIETIN FUSION PROTEIN WITH IMPROVED PHARMACOKINETICS |
| US8053183B2 (en) * | 2005-07-27 | 2011-11-08 | Oncotherapy Science, Inc. | Method of diagnosing esophageal cancer |
| US7846445B2 (en) | 2005-09-27 | 2010-12-07 | Amunix Operating, Inc. | Methods for production of unstructured recombinant polymers and uses thereof |
| KR100888022B1 (ko) * | 2006-12-21 | 2009-03-09 | 재단법인 목암생명공학연구소 | 면역글로불린 Ｆｃ와 인간 아포리포단백질（ａ）크링글절편의 융합단백질 ＬＫ8Ｆｃ |
| CA2687377C (en) | 2007-05-30 | 2013-05-14 | Genexine Co., Ltd. | Immunoglobulin fusion proteins |
| CN103298935A (zh) * | 2007-08-15 | 2013-09-11 | 阿穆尼克斯公司 | 用于改善生物活性多肽性能的组合物和方法 |
| CN101891823B (zh) | 2010-06-11 | 2012-10-03 | 北京东方百泰生物科技有限公司 | 一种Exendin-4及其类似物融合蛋白 |
| KR101847523B1 (ko) | 2011-01-24 | 2018-05-28 | 연세대학교 산학협력단 | 조절자 Ｔ 세포에 특이적으로 존재하는 새로운 표면단백질 Ｌｒｉｇ-1의 용도 |
| LT3401402T (lt) | 2012-06-08 | 2020-12-28 | Alkermes Pharma Ireland Limited | Ligandai, modifikuoti cirkuliarinės permutacijos pagalba, kaip agonistai ir antagonistai |
| EP2904004B1 (en) | 2012-10-04 | 2018-11-21 | Research Development Foundation | Serine protease molecules and therapies |
| EP3029071B1 (en) | 2013-07-30 | 2018-07-11 | Industry-Academic Cooperation Foundation, Yonsei University | Saxatilin-fc fusion protein and use thereof |
| AU2019309472A1 (en) | 2018-07-24 | 2021-03-18 | Good T Cells, Inc. | Composition for preventing or treating immune-related diseases |
-
2019
- 2019-04-26 WO PCT/KR2019/005096 patent/WO2019209078A1/ko not_active Ceased
- 2019-04-26 CN CN201980028463.XA patent/CN112041333B/zh active Active
- 2019-04-26 KR KR1020190049295A patent/KR102194644B1/ko active Active
- 2019-04-26 JP JP2020559369A patent/JP7485368B2/ja active Active
- 2019-04-26 EP EP19793399.7A patent/EP3792276A4/en not_active Withdrawn
- 2019-04-26 US US17/050,816 patent/US11820801B2/en active Active
-
2020
- 2020-12-17 KR KR1020200177336A patent/KR20200144524A/ko not_active Ceased
-
2023
- 2023-10-04 KR KR1020230131463A patent/KR102754984B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7690285B2 (ja) | 結合タンパク質１ | |
| JP7485368B2 (ja) | 新規な融合タンパク質およびこれを含む癌の予防または治療用薬学的組成物 | |
| KR102501921B1 (ko) | 유도성 결합 단백질 및 사용 방법 | |
| JP6783797B2 (ja) | 抗がん融合ポリペプチド | |
| JP2024113039A (ja) | 腫瘍壊死因子 （ｔｎｆ） スーパーファミリー受容体結合分子およびその使用 | |
| CN102131524B (zh) | 成纤维细胞生长因子受体2的单克隆抗体 | |
| JP2022025071A (ja) | グリコシル化ｐｄ－１に対して特異的な抗体およびその使用方法 | |
| EP2589609A1 (en) | Antigen binding protein and its use as addressing product for the treatment of cancer | |
| KR102652664B1 (ko) | 조절 t 세포 표면 항원의 에피토프 및 이에 특이적으로 결합하는 항체 | |
| CN112794911B (zh) | 人源化抗叶酸受体1抗体及其应用 | |
| CN110028584A (zh) | 针对egfr蛋白和met蛋白的双特异性抗体 | |
| JP7827890B2 (ja) | Ｐｒｌｒ抗原結合タンパク質、その製造方法及び使用 | |
| CN117255806A (zh) | 结合trop2的抗体及其用途 | |
| MX2011005382A (es) | Anticuerpos anti-her4 especificos de isoforma. | |
| KR20220088428A (ko) | 글리코실화된 ctla-4에 대해 특이적인 항체 및 이의 사용 방법 | |
| JPWO2019209078A5 (enExample) | ||
| KR20130057959A (ko) | 항 ｈｅｒ2 단일클론항체와 ｉｌ-2를 포함하는 융합 단일클론 항체 및 이를 포함하는 암치료용 조성물 | |
| AU2015263827B2 (en) | Bak binding proteins | |
| JP2025535386A (ja) | ＴＲＡＩＬまたはＦａｓＬに特異的に結合する抗体の組み合わせおよび二重特異性抗体 | |
| WO2024173565A2 (en) | Human synthetic antibodies targeting human epidermal growth factor receptor 2 (her2) mutants | |
| HK40069309A (en) | Constructs targeting afp peptide/mhc complexes and uses thereof | |
| TW202602928A (zh) | 程序性死亡配體1(pd-l1)嵌合抗原受體及其應用 | |
| JP2003047470A (ja) | 新規な抗体及びその用途 | |
| KR20220088438A (ko) | 글리코실화된 lag3에 대해 특이적인 항체 및 이의 사용 방법 | |
| KR20210017449A (ko) | 신규한 융합 단백질 및 이의 용도 |